STS-135 (drug)

From WikiMD's WELLNESSPEDIA

STS-135 is a synthetic cannabinoid that is also a designer drug. It was first detected in smoking products in Japan in 2012. The drug is named after the Space Shuttle Atlantis's final mission, STS-135.

Chemistry[edit]

STS-135 is a derivative of Adamantane, a synthetic diamond. It is part of the naphthoylindole family, which also includes JWH-018 and AM-2201. These are all cannabinoid receptor agonists. STS-135 is a CB1 receptor agonist, which is the same receptor that THC, the main active ingredient in cannabis, binds to.

Effects[edit]

The effects of STS-135 are similar to those of other synthetic cannabinoids and include euphoria, relaxation, and altered perception. However, it also has a number of negative effects, including anxiety, paranoia, and psychosis. It is also associated with a number of health risks, including tachycardia, hypertension, and seizures.

Legal Status[edit]

STS-135 is illegal in many countries, including the United States, where it is classified as a Schedule I drug. It is also illegal in the United Kingdom, where it is classified as a Class B drug.

See Also[edit]

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


  • 5F-APICA.svg
    5F-APICA.svg

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=STS-135_(drug)&oldid=6337317"